Editorial: Multi Target - Directed Ligands in the Treatment of Alzheimer’s Disease

Author(s): Ondrej Soukup, Jan Korabecny

Journal Name: Current Alzheimer Research

Volume 16 , Issue 9 , 2019

Become EABM
Become Reviewer

[1]
Mezeiova E, Chalupova K, Nepovimova E, Gorecki L, Prchal L, Malinak D, et al. Donepezil derivatives targeting amyloid-β cascade in Alzheimer’s disease. Curr Alzheimer Res 16(9): 772-800. (2019).
[2]
Knez D, Sosič I, Pišlar A, Mitrović A, Jukič M, Kos J, et al. Biological evaluation of 8-hydroxyquinolines as multi-target directed ligands for treating Alzheimer’s disease. Curr Alzheimer Res 16(9): 801-14. (2019).
[3]
Malek R, Refouvelet B, Benchekroun M, Iriepa I, Andrys IMR, Musilek K, et al. Synthesis and biological evaluation of novel chromone+donepezil hybrids for Alzheimer’s disease therapy. Curr Alzheimer Res 16(9): 815-20. (2019).
[4]
Kaniakova M, Nepovimova E, Kleteckova L, Skrenkova K, Holubova K, Chrienova Z, et al. Combination of memantine and 6-chlorotacrine as novel multi-target compound against Alzheimer’s disease. Curr Alzheimer Res 16(9): 821-33. (2019).


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 9
Year: 2019
Page: [771 - 771]
Pages: 1
DOI: 10.2174/156720501609191029115310

Article Metrics

PDF: 27
HTML: 5